Clinical Trials

Can we trust the integrity of clinical trials?

AstraZeneca's George Kirk tells us the story of Koselugo – a treatment for the rare genetic condition neurofibromatosis 1.

From patient recruitment to distributing products, we ask how clinical trials can weather the COVID-19 pandemic.

When developing countermeasures against COVID-19, resource-poor settings should not be forgotten.

In what may have been one of the last advanced therapy meetings to go ahead for some time, delegates met in London in late February for CAR-TCR.

We catch up with a new CEO about his goals for a clinical trials business.

Why are compounds still failing at the final hurdle?

What challenges do manufacturers face in developing ADCs?

John Rossi, Director of Translational Sciences at Kite Pharma, talks about bright future of CAR T cell therapy.

A cell-free biologic could act as platform therapeutic for a variety of serious diseases.